← Stocks · BIVI record
Signal record & history · Trifecta Signals
Biovie has been flagged by the Trifecta screener 1 time since 2024. 1 signal confirmed; the median confirmed signal is down 97.5% since its Early Signal.
Price refreshes every trading day after the close.
Full interactive chart ↗ · partner link
Daily closes · through the most recent close
Price history from Jan 2018 · Signal tracking began Jan 2022
Headline statistics: confirmed signals only, measured from the confirmation price.
First signal Mar 2024 · Latest Mar 2024 · Confirmed 1 of 1 Early · Latest close in the chart data: Thu, Nov 5, 2026
Groups are mutually exclusive — every confirmed signal sits in exactly one.
Since March 2024, Biovie has had one Early signal, one confirmed. Its one decided signal did not reach +10% within 90 days, and it did not finish ahead of the S&P 500 since confirmation.
Every Early signal in the record, newest first.
Members see every signal below, and the group mix above.
Membership unlocks the complete signal timeline for BIVI and every other stock in the record — group tags, caution flags, and the full screener.
Already a member? Sign in and this page unlocks.
Biovie sits in the Healthcare sector, in the Drug Manufacturers - Specialty & Generic industry. With a market value of about $15 million, the company falls in the small-cap group.
The strongest run on Biovie’s record followed a confirmation in April 2024, falling about 29% over the following 90 days. Classification adds texture: it sat in the mid-cap group when that signal fired.
BIVI closed Thursday, November 5 at $1.21, down 9.7% on the day. The last five sessions span about $1.21 to about $1.73.
